Market Overview: US Stocks Narrowly Mixed, ETF Funds Show Clear Divergence
On July 28, 2026, the three major US stock indexes closed mixed: the Dow edged down 0.1%, the S&P 500 was flat, while the Nasdaq Composite rose 0.25% to 19,875. Markets await next week's Fed meeting and tech giant earnings, with overall trading light. Against this backdrop, US stock ETF fund flows diverged: growth tech ETFs saw buy-side support, while high-dividend ETFs continued to attract defensive capital. This article reviews the day's performance and strategy for core categories including NASDAQ 100 ETFs, semiconductor ETFs, dividend ETFs, and healthcare ETFs.
NASDAQ 100 ETF: Volatility Hides Positive Signals
ETFs tracking the Nasdaq 100 generally edged higher. The largest, QQQ, rose 0.3% to $392.50 with about $8.5 billion in turnover. The intraday range was narrow, reflecting caution on both sides. Notably, QQQ has consolidated near $390 for two straight weeks since mid-July, forming a technical "flag" pattern that may signal an imminent breakout. Among components, large-cap tech stocks were mixed: Apple edged down 0.2%, Amazon up 0.5%, Google flat. Fund flow data shows NASDAQ 100 ETFs attracted a cumulative net inflow of about $1.2 billion over the past five trading days through July 28, indicating institutional investors are still buying on dips. For dollar-cost averaging investors, the current range offers a good entry point for phased accumulation.
Semiconductor ETF: NVIDIA Rumors Spark Sector
Semiconductor ETFs were the day's standout. Driven by market rumors that NVIDIA secured a custom AI chip order from a major cloud provider, SMH (VanEck Semiconductor ETF) rose 1.8% to $218, leading all sector ETFs. SOXX (iShares Semiconductor ETF) also gained 1.6%. NVIDIA shares surged 3.5%, lifting the entire semiconductor sector. Analysts note that while the rumor is unconfirmed, the semiconductor industry is in an upcycle driven by AI computing demand, with chip inventory at historical lows and capacity utilization near full. On ETF fund flows, SMH recorded net inflows of $450 million over the past week, reflecting strong investor confidence. For higher-risk-tolerant investors, buying opportunities may appear after pullbacks, but short-term volatility should be noted.
Dividend ETF: High-Dividend Strategy Remains Popular
In a high-rate environment, dividend ETFs continued to show defensive traits. VYM (Vanguard High Dividend Yield ETF) edged down 0.1% to $115.80 but still attracted net fund inflows of $230 million. SCHD (Schwab US Dividend Equity ETF) saw $180 million net inflows with its price roughly flat. The appeal of dividend ETFs lies in their stable payouts: VYM's current dividend yield is about 3.2%, SCHD about 3.5%, well above the 10-year Treasury yield (~2.9%). As expectations for a Fed rate cut in September rise, the capital appreciation potential of dividend ETFs is being reassessed. Senior ETF strategists point out that utilities and consumer staples within the dividend sector have reasonable valuations, making them suitable as portfolio "anchors." It is recommended that regular investors maintain monthly fixed contributions to average costs amid market fluctuations.
Healthcare ETF: Small Fund Inflows, Focus on Weight-Loss Drugs
Healthcare ETFs had a mild day. XLV (Health Care Select Sector SPDR Fund) rose 0.3% to $142, with net fund inflows of about $120 million. IBB (iShares Biotechnology ETF) gained 0.5% but had lower turnover. Within sub-sectors, weight-loss drug stocks like Eli Lilly and Novo Nordisk continued to attract attention, with Lilly hitting a record high, boosting related ETF holdings. However, healthcare ETFs have recently underperformed the broader market, weighed by uncertainty over US drug pricing reform negotiations. Long-term growth logic remains supported by aging demographics and biotech innovation. For long-term investors, current healthcare ETF valuations are below the three-year median, making phased accumulation a potential opportunity.
Fund Flow Summary: Growth vs. Value Seesaw Effect
Overall ETF fund flow data shows growth tech ETFs (NASDAQ 100, semiconductor) had combined net inflows of about $1.6 billion, while defensive dividend ETFs attracted $400 million, exhibiting a "seesaw" effect. This suggests the market is still weighing soft landing versus recession risks. Additionally, broad-based ETFs like SPY (SPDR S&P 500) and VOO (Vanguard S&P 500) saw small net outflows, indicating investors favor sector/theme ETFs over broad market bets. Looking ahead, next week's Fed rate decision and earnings from Apple and Microsoft will determine near-term direction. Operationally, a "core + satellite" strategy is advised: use broad-based ETFs as long-term holdings and supplement with semiconductor or dividend ETFs for excess returns.
Practical Guide: How Beginners Choose and Dollar-Cost Average
For US stock investing beginners, ETF dollar-cost averaging is the simplest approach. Specifically:
- NASDAQ 100 ETF (QQQ/QQQM): Best long-term growth potential, suitable for a horizon of 5+ years; regular fixed amounts smooth volatility.
- Semiconductor ETF (SMH/SOXX): Higher volatility; consider increasing DCA when sector faces short-term headwinds or when price pulls back to the 20-day moving average.
- Dividend ETF (VYM/SCHD): Ideal for stable cash flow; allocate about 30% of total monthly DCA to dividend ETFs, reinvesting dividends for compounding.
- Healthcare ETF (XLV/IBB): Light allocation as a defensive component; reduce DCA frequency to once per quarter.
